About Us
Regulatory Compliance
Exceeding Expectations:
- JCAHO (Joint Commission for the Accreditation of Healthcare Organizations)
- ASHP (American Society of Health-Systems Pharmacists)
- CALIFORNIA SENATE BILL 1875
JCAHO
A recent study published by the Advisory Board’s Clinical Initiatives Center (CIC), as reported by the Joint Commission, focuses on the best practices for preventing ADEs, the most frequent cause of accidental patient injury noted in the report. The Dynamic Monitoring™ System (DPM) meets or exceeds each of the CIC’s three recommendations:
CIC Recommendation: High-risk rounding list. Pharmacy information systems should be able to generate a daily roster of patients on high-risk or high-cost drug therapies; and clinical pharmacists should use lists to identify patients most likely to need an intervention to prevent an ADE.
DPM Solution: The DPM system exceeds this recommendation by automatically and continuously screening all patient files 24/7.DPM makes rounds more efficient by automatically notifying pharmacy personnel only when there is a risk to a patient that is in need, or may soon be in need, of intervention. Thus, patients are automatically screened and identified.
CIC Recommendation: Pharmacy-managed protocols. Hospitals should implement collaborative drug therapy regimens established by physicians and managed by hospital pharmacists who are empowered to dose and readjust drug therapy as needed.
DPMSolution: The DPM system offers clinicians timely information for optimal clinical intervention before the ADE occurs, not after complications from an ADE have begun. The DPM system supports the clinical decision-making process through the use of its unique and innovative features such as monitoring and alerting according to your hospital’s renal dosing protocol. Through automation, DPM provides meaningful information when clinicians need it most.
CIC Recommendation: Automated ADE monitoring. The pharmacy information system should be designed to conduct an automated scan for medication-prescribing errors and critical lab results with the potential for generating an ADE. The system should also be designed to generate an alert list that describes the problem and offers recommendations.
DPM Solution: The DPM system offers a dynamic real-time approach in merging patient, lab and drug order data for all hospital patients. The DPM system works as an automated monitor, using a proprietary surveillance search engine that works 24/7 to identify existing or potential ADEs along with the appropriate recommended action to prevent them.
ASHP
The following 2015 goals are met by the DPM Solution:
Goal 3: Increase the extent to which health-system pharmacists actively apply evidence-based methods to the improvement of medication therapy.
Objective 3.1
For 100% of health-system patients, pharmacists will be actively involved in ensuring that they receive evidence-based medication therapy
Baseline 74.2%DPM Solution: The DPM system offers a dynamic real-time tool which enables the pharmacist to monitor merged patient, lab and drug order data for all hospital patients. Recommended guidance is provided based upon the individual hospital’s evidence-based medication therapy practice guidelines.
Objective 3.2
In 100% of health systems, pharmacists will be actively involved in the development and implementation of all evidence-based therapeutic protocols involving medication use.
Baseline 95.3% (95% CI, 92.6–97.0%)DPM Solution:The DPM system offers a dynamic real-time tool that enables the pharmacist to implement rules that monitor and ensure adherence to their own evidence-based therapeutic protocols involving medication use. These rules can be selected from an extensive library of over 1,000 rules that have been developed by other clinicians. Or they can easily build out their own custom rules without the need for IT support.
Objective 3.31
90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction or congestive heart failure will receive angiotensin-converting enzyme inhibitors or angiotensin receptor blockers at discharge.
Baseline 19.7% (95% CI, 15.9–24.0%)DPM Solution: The DPM system offers a dynamic real-time tool that enables the pharmacist to ensure that the clinician is proactively notified in real time, on an exception basis, whenever a patient is hospitalized for an acute myocardial infarction or congestive heart failure without receiving angiotensin-converting enzyme inhibitors or angiotensin receptor blockers at discharge.
Objective 3.4
90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction will receive beta-blockers at discharge.
Baseline 17.2% (95% CI, 13.7–21.4%)DPM Solution: The DPM system offers a dynamic real-time tool that proactively notifies the pharmacist in real time, on an exception basis, when patients hospitalized for an acute myocardial infarction do not receive beta-blockers at discharge.
Objective 3.5
90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction will receive aspirin at discharge.
Baseline 18.1% (95% CI, 14.5–22.5%)DPM Solution: The DPM system offers a dynamic real-time tool that proactively notifies the pharmacist in real time, on an exception basis, when patients hospitalized for an acute myocardial infarction do not receive aspirin at discharge.
Objective 3.6
90% of hospital pharmacies will participate in ensuring that patients hospitalized for an acute myocardial infarction will receive lipid-lowering therapy at discharge.
Baseline 10.5% (95% CI, 7.8–13.9%)DPM Solution: The DPM system offers a dynamic real-time tool that proactively notifies the pharmacist in real time, on an exception basis, when patients hospitalized for an acute myocardial infarction do not receive lipid-lowering therapy at discharge.
CALIFORNIA SENATE BILL 1875
This law requires hospitals, as a condition of licensure, to implement by Jan. 1, 2005 a plan to substantially reduce medication-related errors. Plans must include implementation of technology that has been shown effective in eliminating or substantially reducing medication-related errors. CSB 1875
DPM Solution: The DPM system offers clinicians timely information and guidance for optimal clinical intervention before the ADE occurs, not after complications from an ADE have begun. Working with merged patient, drug and lab data from your existing clinical systems, the DPM system supports the clinical decision-making process through the use of its unique and innovative features such as monitoring and alerting according to your hospital’s renal dosing protocol.